BioMarin (United States)
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research is in enzyme replacement therapies. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for BioMarin (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
58%
Total
Publications
815
Total Open
Publications
475
Total
Citations
32K
Open Access
Percentage
58%
Total
Publications
815
Total Open
Publications
475
Total
Citations
32K
Breakdown
Publisher Open
17%
Both
32%
Other Platform Open
9%
Closed
42%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 35%
142
Hybrid 45%
180
No Guarantees 20%
80
Other Platform Open
Domain 82%
277
Institution 27%
93
Other Internet 12%
40
Preprint 8%
26
Public 7%
23
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 273 |
Europe PMC | Domain | 146 |
University College London - UCL Discovery | Institution | 44 |
University of California - eScholarship University of California | Institution | 18 |
Semantic Scholar | Public | 18 |
California Digital Library - eScholarship | Other Internet | 14 |
bioRxiv | Preprint | 13 |
Research Square | Preprint | 9 |
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia | Other Internet | 9 |
DOI | Other Internet | 9 |